Value Sense
IDXX
IDEXX Laboratories, Inc. (IDXX)
Last Price$437.20.0%
Market Cap$36.1B
Intrinsic value score
7/10
Great
Intrinsic value
$219.3
DCF value - $139.8 Relative value - $298.9
Overvalued
49.8%
LTM P/E
40.7x
Peer set median 29.0x
Discount rate
10.3%
IDXX
is 49.8% overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

IDXX Intrinsic value

Key Highlights:
Relative Value vs Current Share Price
As of Mar 03, 2025 IDXX Relative Value is $300.8, which is overvalued by 31.2%, compared to current share price of $437.2.
DCF Value vs Current Share Price
As of Mar 03, 2025 IDXX DCF Value is $138.8, which is overvalued by 68.2%, compared to current share price of $437.2.
Methodology
Price per share, $
IDXX
Intrinsic value$219.3
Overvalued by49.8%
Current share price
437.2
Relative value
300.8
DCF value
138.8

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

IDXX Historical Intrinsic Value

Crunching data... Almost there!

IDXX vs Peer Set: Intrinsic Value Comparison

General

Intrinsic Value

Financials

Company name

Undervaluation/Overvaluation

Revenue growth

EPS growth

Net income margin

IDEXX Laboratories, Inc. logo
IDEXX Laboratories, Inc.IDXX
(49.8%)
8.7%
25.2%
23.1%
Median Peer Set
(1.7%)
(7.2%)
11.6%
Natera, Inc. logo
Natera, Inc.NTRA
(50.4%)
32.0%
(32.1%)
(40.2%)
Waters Corporation logo
Waters CorporationWAT
(36.5%)
(0.5%)
(7.9%)
21.7%
Mettler-Toledo International Inc. logo
Mettler-Toledo International Inc.MTD
(31.5%)
2.2%
12.7%
22.3%
Danaher Corporation logo
Danaher CorporationDHR
(18.8%)
(0.1%)
(17.9%)
16.3%
Agilent Technologies, Inc. logo
Agilent Technologies, Inc.A
(17.9%)
(4.7%)
5.0%
19.8%
Thermo Fisher Scientific Inc. logo
Thermo Fisher Scientific Inc.TMO
15.0%
(4.6%)
(12.4%)
14.0%
IQVIA Holdings Inc. logo
IQVIA Holdings Inc.IQV
63.0%
2.8%
2.4%
8.9%
Illumina, Inc. logo
Illumina, Inc.ILMN
74.8%
(2.9%)
4.6%
(28.0%)
Quest Diagnostics Incorporated logo
Quest Diagnostics IncorporatedDGX
109.0%
(6.4%)
(6.5%)
9.2%
Laboratory Corporation of America Holdings logo
Laboratory Corporation of America HoldingsLH
144.4%
(18.3%)
(65.8%)
3.4%

Explore more intrinsic value tools hub for IDXX

DCF value calculator
Reverse DCF
Peter Lynch charts
Relative Value
Earnings growth model
Peter Lynch Fair Value
Margin of safety
Ben Graham Fair Value
Earnings Power Value
Discount rate

FAQ

What is IDEXX Laboratories, Inc. intrinsic value?

As of Mar 03, 2025, IDEXX Laboratories, Inc. Intrinsic Value is $219.3. This suggests it may be overvalued by 49.8% compared to its current price of around $437.2.

What is IDEXX Laboratories, Inc. DCF (discounted cash flow) valuation?

As of Mar 03, 2025, IDEXX Laboratories, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $138.8. This suggests it may be overvalued by 68.2% to its current price of around $437.2, using a discount rate of 10.3% and terminal growth rate of 3.0%.

Is IDEXX Laboratories, Inc. overvalued or undervalued?

IDEXX Laboratories, Inc. is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $219.3, compared to a market price of around $437.2. This suggests a potential overvaluation of 49.8%.